CSF PKR Is a Diagnostic and Prognostic Marker in Alzheimer's Disease

被引：0
|
作者：
Hugon, Jacques [1 ]
Liger, Francois Mouton [1 ]
Dumurgier, Julien [1 ]
Laplanche, Jean Louis [1 ]
Paquet, Claire [1 ]
机构：
[1] Lariboisiere Fernand Widal Hosp, Memory Ctr, Paris, France
来源：
NEUROLOGY | 2013年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P03073
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Potential prognostic value of CSF-targeted proteomics across the Alzheimer's disease continuum
    Xu, Bingdong
    Ling, Yitong
    Liu, Leiyuan
    Liu, Yujun
    Lin, Yingze
    Lyu, Jun
    Zhang, Yusheng
    BMC GERIATRICS, 2024, 24 (01)
  • [42] Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer's disease
    Libiger, Ondrej
    Shaw, Leslie M.
    Watson, Mark H.
    Nairn, Angus C.
    Umana, Kelly L.
    Biarnes, Michael C.
    Canet-Aviles, Rosa M.
    Jr, Clifford R. Jack
    Breton, Yannick-Andre
    Cortes, Laetitia
    Chelsky, Daniel
    Spellman, Daniel S.
    Baker, Susan A.
    Raghavan, Nandini
    Potter, William Z.
    ALZHEIMERS & DEMENTIA, 2021, 17 (12) : 1976 - 1987
  • [43] Chemokines in CSF of Alzheimer's disease patients
    Correa, Joice Dias
    Starling, Daniela
    Teixeira, Antonio Lucio
    Caramelli, Paulo
    Silva, Tarcilia Aparecida
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2011, 69 (03) : 455 - 459
  • [44] CSF epinephrine in aging and Alzheimer's disease
    Peskind, ER
    Elrod, R
    Digiacomo, L
    Veith, RC
    Raskind, MA
    BIOLOGICAL PSYCHIATRY, 1996, 39 (07) : 542 - 542
  • [45] A three-range approach enhances the prognostic utility of CSF biomarkers in Alzheimer's disease
    Brum, Wagner S.
    de Bastiani, Marco Antonio
    Bieger, Andrei
    Therriault, Joseph
    Ferrari-Souza, Joao P.
    Benedet, Andrea L.
    Saha-Chaudhuri, Paramita
    Souza, Diogo O.
    Ashton, Nicholas J.
    Zetterberg, Henrik
    Pascoal, Tharick A.
    Karikari, Thomas
    Blennow, Kaj
    Rosa-Neto, Pedro
    Zimmer, Eduardo R.
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2022, 8 (01)
  • [46] CSF markers in MCI and Alzheimer's disease
    Blennow, K
    INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 : 7 - 8
  • [47] CSF and Blood Biomarkers for Alzheimer's Disease
    Herskovits, A. Zara
    Ivinson, Adrian J.
    Scherzer, Clemens R.
    Hyman, Bradley T.
    Lindeman, Neal
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 138 (03) : 469 - 469
  • [48] CSF markers for incipient Alzheimer's disease
    Blennow, K
    Hampel, H
    LANCET NEUROLOGY, 2003, 2 (10): : 605 - 613
  • [49] Novel CSF biomarkers for Alzheimer's disease
    Burchell, Jennifer T.
    Panegyres, Peter K.
    FUTURE NEUROLOGY, 2015, 10 (06) : 511 - 514
  • [50] CSF markers for early Alzheimer's disease
    Blennow, K
    Davidsson, P
    Vanmechelen, E
    ALZHEIMER'S DISEASE: ADVANCES IN ETIOLOGY, PATHOGENESIS AND THERAPEUTICS, 2001, : 275 - 283
12345